Table 4.
Univariate analysis of the correlation between clinicopathological parameters and overall survival time of HCC patients.
| Variable | Mean survival time (m) | 95% CI | P |
|---|---|---|---|
| Gender | |||
| Male | 32.341 | 21.511–43.171 | 0.943 |
| Female | 30.505 | 26.228–34.781 | |
| Age at surgery (yeas) | |||
| ≤60 | 31.999 | 26.799–37.199 | 0. 389 |
| >60 | 27.550 | 22.750–32.350 | |
| Tumor size (cm) | |||
| ≤5 | 34.738 | 28.539–40.938 | 0.082 |
| >5 | 27.087 | 22.083–32.092 | |
| HbsAg | |||
| Negative | 31.652 | 27.185–36.119 | 0. 361 |
| Positive | 23.592 | 17.896–29.288 | |
| Cirrhosis | |||
| No | 30.650 | 26.405–34.894 | 0.665 |
| Yes | 28.700 | 21.558–35.842 | |
| Child-Pugh | |||
| A | 31.220 | 27.112–35.328 | 0.104 |
| B | 15.667 | 5.529–25.804 | |
| AFP (ng/ml) | |||
| ≤20 | 37.030 | 30.650–43.410 | 0.016 |
| >20 | 28.649 | 23.388–33.910 | |
| Degree of differentiation | |||
| Well/moderate | 33.340 | 28.324–38.356 | 0.034 |
| Poor and not | 23.492 | 17.595–29.389 | |
| TNM stage | |||
| I/II | 40.293 | 34.167–46.420 | 0.000 |
| III/IV | 19.677 | 16.115–23.239 | |
| RBP2 expression | |||
| Negative | 48.395 | 40.477–56.344 | 0.000 |
| Positive | 23.670 | 20.000–27.341 | |